SCHEMBL7379613

SCHEMBL7379613

[CH2]c1cccc(-c2nc(N(C)C)c[nH]2)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDO2 P48775 1/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ AURKA O14965 1/20 0.34
▸ CKS1B P61024 1/20 0.32
▸ SKP1 P63208 1/20 0.32
▸ SKP2 Q13309 1/20 0.32
▸ PRKAG1 P54619 1/20 0.32
▸ PRKAA1 Q13131 1/20 0.32
▸ PRKAB1 Q9Y478 1/20 0.32
▸ MAP3K11 Q16584 1/20 0.31
▸ GABRA1 P14867 1/20 0.31
▸ GABRG2 P18507 1/20 0.31
▸ GABRB3 P28472 1/20 0.31
▸ GABRA5 P31644 1/20 0.31
▸ GABRA3 P34903 1/20 0.31
▸ ADORA2A P29274 1/20 0.31
▸ ADORA1 P30542 1/20 0.31
▸ CNR1 P21554 1/20 0.30
▸ NPC1 O15118 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7377289 0.84 KMT2A (0.35) KMT2ACNR1MGAMGAASI
SCHEMBL4454969 0.80 MEN1 (0.44) MEN1KMT2ACKS1BSKP1SKP2
SCHEMBL7376433 0.79 GAA (0.37) KMT2ANPC1TP53PKMRAB9A
SCHEMBL7376736 0.75 TDO2 (0.33) TDO2GABRA1GABRG2GABRB3GABRA5
SCHEMBL7371967 0.72 GABRG2 (0.35) AURKAGABRA1GABRG2GABRB3GABRA5
SCHEMBL7373915 0.69 SCN2A (0.37) AURKA
SCHEMBL7376476 0.67 NPC1 (0.45) MEN1KMT2ANPC1PKMRAB9A
SCHEMBL17280198 0.67 AURKA (0.50) AURKANPC1TP53RAB9ASMN1; SMN2
SCHEMBL7375026 0.67 RAB9A (0.38) MEN1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL7376460 0.66 NPY5R (0.45) NPC1TP53PKMRAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1997008150-A1 SUBSTITUTED CYCLIC UREAS AND DERIVATIVES THEREOF USEFUL AS RETROVIRAL PROTEASE INHIBITORS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1997-03-06 — — WO claimed
US-5763469-A Substituted cyclic ureas and derivatives thereof useful as retroviral protease inhibitors THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1998-06-09 — — US disclosed
WO-1997008150-A1 SUBSTITUTED CYCLIC UREAS AND DERIVATIVES THEREOF USEFUL AS RETROVIRAL PROTEASE INHIBITORS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1997-03-06 — — WO disclosed
Send feedback